Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,134 | 411 | 99.6% |
| Education | $28.42 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,654 | 82 | $0 (2023) |
| Merck Sharp & Dohme LLC | $646.06 | 45 | $0 (2022) |
| Novo Nordisk Inc | $604.70 | 36 | $0 (2023) |
| Lilly USA, LLC | $573.91 | 34 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $550.41 | 35 | $0 (2021) |
| ABBVIE INC. | $446.43 | 28 | $0 (2022) |
| Arbor Pharmaceuticals, Inc. | $404.90 | 35 | $0 (2022) |
| PFIZER INC. | $306.98 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $298.96 | 18 | $0 (2022) |
| Mannkind Corporation | $276.52 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.35 | 2 | PFIZER INC. ($22.30) |
| 2023 | $306.41 | 16 | PFIZER INC. ($128.30) |
| 2022 | $1,082 | 53 | AstraZeneca Pharmaceuticals LP ($387.09) |
| 2021 | $1,651 | 94 | AstraZeneca Pharmaceuticals LP ($301.86) |
| 2020 | $974.97 | 57 | AstraZeneca Pharmaceuticals LP ($297.72) |
| 2019 | $1,059 | 68 | Merck Sharp & Dohme Corporation ($300.17) |
| 2018 | $1,218 | 64 | MannKind Corporation ($258.38) |
| 2017 | $828.16 | 62 | Janssen Pharmaceuticals, Inc ($145.82) |
All Payment Transactions
416 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Oncology | ||||||
| 08/09/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: HEMATOLOGY | ||||||
| 09/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 06/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, PAXLOVID | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: WOMENS HEALTH | ||||||
| 04/19/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: Diabetes | ||||||
| 04/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/21/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: VACCINES | ||||||
| 02/21/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: VACCINES | ||||||
| 02/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: DIABETES | ||||||
| 02/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 02/13/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, PAXLOVID | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: WOMENS HEALTH | ||||||
| 01/30/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Respiratory | ||||||
| 01/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes Care | ||||||
| 11/18/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Diabetes | ||||||
| 10/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 10/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 337 | 672 | $74,619 | $40,151 |
| 2022 | 4 | 281 | 449 | $65,030 | $36,401 |
| 2021 | 4 | 289 | 439 | $57,205 | $35,869 |
| 2020 | 2 | 209 | 375 | $41,050 | $20,741 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 187 | $25,722 | $11,662 | 45.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 106 | $20,185 | $8,966 | 44.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 38 | 195 | $9,988 | $7,494 | 75.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 23 | 106 | $6,081 | $4,459 | 73.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 27 | 27 | $7,776 | $3,910 | 50.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $3,510 | $2,599 | 74.0% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 18 | 33 | $1,357 | $1,062 | 78.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 191 | $33,425 | $18,101 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 225 | $24,750 | $13,506 | 54.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 19 | $3,705 | $2,718 | 73.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,150 | $2,076 | 65.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 106 | 152 | $23,675 | $15,633 | 66.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 250 | $26,810 | $15,460 | 57.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 26 | $5,070 | $3,834 | 75.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,650 | $941.31 | 57.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 158 | 304 | $30,400 | $14,990 | 49.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 51 | 71 | $10,650 | $5,750 | 54.0% |
About Dr. Shelley Williams, M.D
Dr. Shelley Williams, M.D is a Family Medicine healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598803991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shelley Williams, M.D has received a total of $7,163 in payments from pharmaceutical and medical device companies, with $42.35 received in 2024. These payments were reported across 416 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($7,134).
As a Medicare-enrolled provider, Williams has provided services to 1,116 Medicare beneficiaries, totaling 1,935 services with total Medicare billing of $133,162. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Silver Spring, MD
- Active Since 02/01/2007
- Last Updated 12/29/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598803991
Products in Payments
- FARXIGA (Drug) $1,296
- Trintellix (Drug) $389.51
- JANUVIA (Drug) $380.94
- UBRELVY (Drug) $347.06
- Ozempic (Drug) $334.01
- AFREZZA (Drug) $276.52
- Edarbi (Drug) $274.91
- TRULICITY (Drug) $264.76
- JARDIANCE (Drug) $233.41
- BREZTRI (Drug) $226.07
- XARELTO (Drug) $215.38
- TRINTELLIX (Drug) $204.47
- VRAYLAR (Drug) $164.15
- NURTEC ODT (Drug) $163.07
- Korlym (Drug) $151.60
- STEGLATRO (Drug) $129.72
- MOUNJARO (Drug) $118.36
- Edarbyclor (Drug) $112.23
- BASAGLAR (Drug) $108.14
- ELIQUIS (Drug) $90.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Silver Spring
Dr. Jean Welsh, Md, MD
Family Medicine — Payments: $29,783
Adolph Johnson, M.d, M.D
Family Medicine — Payments: $13,149
Dr. Mark Major, M.d, M.D
Family Medicine — Payments: $9,878
Dr. Carlos Covarrubias Ponce, Md, MD
Family Medicine — Payments: $7,717
Dr. Wendy Wong, M.d, M.D
Family Medicine — Payments: $5,757
Maria Martin, M.d, M.D
Family Medicine — Payments: $4,746